Global Gouty Arthritis Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Gouty Arthritis Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Pharmaceutical
  • Upcoming Report
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Gouty Arthritis Market

Market Size in USD Billion

CAGR :  % Diagram

Chart Image USD 3.62 Billion USD 6.00 Billion 2024 2032
Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 3.62 Billion
Diagram Market Size (Forecast Year)
USD 6.00 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Gouty Arthritis Market Segmentation, By Diagnosis (Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy CT Scan, Others), Treatment (NSAIDs, Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Industry Trends and Forecast to 2032

Gouty Arthritis Market

Gouty Arthritis Market Analysis

The global gouty arthritis market is expected to witness significant growth during the forecast period. The growing acceptance of enhanced R&D on regeneration therapies, and rising incidence are the major drivers driving the gout therapeutics market. It typically affects men more than women and further damage to joints can be avoided by treatment. COVID-19 also had a major impact on the population and market growth.

Global Gouty Arthritis Market Size

Global gouty arthritis market size was valued at USD 3.62 billion in 2024 and is projected to reach USD 6.00 billion by 2032, with a CAGR of 6.50% during the forecast period of 2025 to 2032.

Report Scope and Market Segmentation       

Attributes

Gouty Arthritis Key Market Insights

Segmentation

  • By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy CT Scan, Others
  • By Treatment: NSAIDs, Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others
  • By Technology: Oral, Parenteral, Topical, Others
  • By End User: Hospitals, Specialty Clinics, Others
  • By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Key Market Players

Pfizer Inc. (U.S.), Abbvie Inc. (U.S.), Novartis AG (Switzerland), Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH. (Germany), Samsung Bioepis. (South Korea), Merck & Co Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceuticals Industries Ltd. (Israel), AstraZeneca (U.K.), BioCryst Pharmaceuticals, Inc. (U.S.), JW Pharmaceutical (South Korea), Addex Therapeutics (Switzerland)

Market Opportunities

  • Increase in Elderly Population

Gouty Arthritis Market Definition

Gouty arthritis is a common and complex form of inflammatory arthritis that affects anyone. It is characterized by severe pain in joint especially in big toe joint, redness, swelling and tenderness in joint. Gouty arthritis developed due to the accumulation of uric acid in joint which causes pain and inflammation. If left untreated, this condition may damage joints or kidneys as excessive accumulation of uric acid crystals would lead to kidney stone or failure. In majority of cases, it is witnessed with other metabolic diseases or conditions such as obesity, hypertension, and diabetes.

Gouty Arthritis Market Dynamics

Drivers

  • High Prevalence of Chronic Diseases

According to a 2014 study published in the Journal of Rheumatology, about 75% of patients with gouty arthritis have high blood pressure. Therefore, patients suffering from chronic illness are at increased risk of developing gouty arthritis. The high prevalence of gouty arthritis is expected to drive the growth of the global gouty arthritis market.

  • Increased alcohol intake

Increased alcohol consumption is expected to drive the expansion of the gouty arthritis market during the forecast period as a result of the association between increased gout incidence and alcohol consumption and gout.

Opportunities

  • Increase in Elderly Population

Life expectancy is growing around the world, which has led to an increase in the aging population. This trend positively impacts the industry by increasing the incidence of the disease and creating per capita demand for its remedies.

Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified personnel who are unable to perform the treatments could curb the growth of the global gouty arthritis market over a forecast period.

  • High Cost

The huge expenditure required for treatment process surely hamper the market growth.

This global gouty arthritis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global gouty arthritis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Gouty Arthritis Market Scope

The global gouty arthritis market is segmented on the basis of diagnosis, treatment, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis

  • Joint Fluid Test
  • Blood Test
  • X-Ray Imaging
  • Ultrasound
  • Dual Energy CT Scan
  • Others

Treatment

  • NSAIDs
  • Pain Reliever
  • Corticosteroids
  • Xanthine Oxidase Inhibitors
  • Uricosurics
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Topical
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

Gouty Arthritis Market Regional Analysis

The global gouty arthritis market is analyzed and market size insights and trends are provided by diagnosis, treatment, route of administration, end-user and distribution channel as referenced above.

The major countries covered in the global gouty arthritis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to increased prevalence of joint disease, and technological advancements in early diagnosis of the disease.

Asia-Pacific is expected to grow during forecast period due to increased joint replacement surgeries, increased awareness for joint disorders through advertisement & media and rapidly improving health care infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Gouty Arthritis Market Share

The global gouty arthritis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global gouty arthritis market

Gouty Arthritis Market Leaders Operating in the Market Are:

  • Pfizer Inc. (U.S.)
  • Abbvie Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Amgen Inc. (U.S.)
  • Boehringer Ingelheim International GmbH. (Germany)
  • Samsung Bioepis. (South Korea)
  • Merck & Co Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceuticals Industries Ltd. (Israel)
  • AstraZeneca PLC (U.K.)
  • BioCryst Pharmaceuticals, Inc. (U.S.)
  • JW Pharmaceutical Corporation (South Korea)
  • Addex Therapeutics (Switzerland)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The major players operating in the Gouty Arthritis Market are Pfizer Inc. (U.S.), Abbvie Inc. (U.S.), Novartis AG (Switzerland), Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH. (Germany), Samsung Bioepis. (South Korea), Merck & Co Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceuticals Industries Ltd. (Israel), AstraZeneca (U.K.), BioCryst Pharmaceuticals, Inc. (U.S.), JW Pharmaceutical (South Korea), Addex Therapeutics (Switzerland).
The major countries covered in the Gouty Arthritis Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Testimonial